Call for Abstract

10th International Conference on Chronic Obstructive Pulmonary Disease, will be organized around the theme “Scrutinizing the challenges and developing novel approaches for COPD treatment”

Copd Congress 2020 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Copd Congress 2020

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

Respiratory Diseases are pathological conditions affecting the organs and tissues that make gas (Oxygen and Carbon dioxide) exchange difficult in respiration. Common respiratory diseases are Chronic obstructive pulmonary disease, Asthma, Pneumonia, Bronchitis, Cystic Fibrosis, Tuberculosis. Among all the respiratory diseases, about 65 million people suffer from chronic obstructive pulmonary disease (COPD)


  • Track 1-1Obstructive lung disease
  • Track 1-2Chronic Respiratory Disease
  • Track 1-3Pulmonary vascular disease

\r\n The alternative name of Pulmonary hypertension  is  pulmonary arterial hypertension (PAH). Pulmonary hypertension arises when the pressure in the blood vessels that carry the blood from heart to lungs is higher than normal level . Pulmonary hypertension can also happen on its own or it can be caused by additional disease or condition. It shows the symptoms such as shortness of breath, chest pain, and lightheadedness. If the patients are left untreated life-threatening complications like heart failure or arrhythmias can occur





  • Track 2-1Cardiovascular risk
  • Track 2-2Disturbance in airflow
  • Track 2-3Incidence
  • Track 2-4Rates and mortality

Chronic obstructive pulmonary disease (COPD) causes when there is long term exposure to irritants that damage your lungs and airways. It comprises chronic bronchitis and emphysema. Emphysema is a disease of alveoli, making the alveoli lose its elasticity and Chronic Bronchitis is a condition where the Inflammation in the bronchial tube takes place .COPD  is an abiding  lung disease that makes one hard to breathe. COPD is a prevalent condition which mainly affects adults who smoke. Breathing in smoke and the chemicals can damage  the airways and air sacs.

  • Track 3-1Causes of COPD
  • Track 3-2Symptoms
  • Track 3-3Treatment
  • Track 3-4Incidence

Cancer is a disease where in the cells of  the body grow out of control. When cancer observed in the lungs, it is called lung cancer. Lung cancers usually are categorized into two main types called small cell and non-small cell. These two types of lung cancer grow differently and are treated differently. Non-small cell lung cancer is more prominent than small cell lung cancer The recommended screening test for lung cancer is low-dose computed tomography.

  • Track 4-1Oncogenes responsible
  • Track 4-2Spread of tumour
  • Track 4-3Treatment
  • Track 4-4Chemotherapy

Asthma is a long-term problem in the tubes that carry air into the lungs that can make it hard to breathe. The airways get narrow , so air cannot move easily. It can source serious wheezing and breathlessness, known as asthma attacks. Peak flow score will give a sign warn that an asthma attack might happen soon. Most people can control their symptoms. Asthmatic  patient need to take medicine every day to prevent asthma attacks.

  • Track 5-1Modern Techniques in Diagnosis
  • Track 5-2Medication and Cure
  • Track 5-3Symptoms
  • Track 5-4Treatment

Pulmonary Infectious diseases occur when the lungs are infected with bacteria,  virus, or  fungus. Some types of Chronic Pulmonary Infections are Tuberculosis, Pneumonia, Histoplasmosis, Pleural Effusion, Pulmonary infections are treatable, particularly when diagnosed early. Many other infections or diseases may also mimic these infections Fevers for more than a week Cough for more than three weeks, Swollen lymph nodes (glands) in your neck, Coughing up blood.

  • Track 6-1Causative agents
  • Track 6-2Types of infectious diseases
  • Track 6-3Symptoms
  • Track 6-4Treatment

The histology of pathologic descriptions of the lung  disease that is now known as COPD. It describes the pathology and the description of emphysema and its diversity from tuberculosis The diseases that lead to COPD include emphysema, chronic bronchitis, and refractory asthma. All of these has different effects on the lungs and respiratory system. It is a progressive condition, where in the meaning that it gets worse over time.

  • Track 7-1Pathogenesis
  • Track 7-2Causative organisms
  • Track 7-3Incidence
  • Track 7-4Symptoms and Diagnosis
  • Track 7-5Treatment

Smoking remains the most prominent risk factor for COPD in world, other risk factors, including genetic factors and occupational or environmental exposures, remain important. COPD remains a grave public health problem that is regularly underdiagnosed, particularly in its early stages. The respiratory indications of cough and phlegm amplified with existing smoking and age among both in  men and women.

  • Track 8-1Causative agents
  • Track 8-2Pathogenesis
  • Track 8-3Incidence rate and risk factor
  • Track 8-4Prevalence rate

Chronic inflammation  and immune responses play a vital  roles in the development and advancement of COPD. The role in the NLRP3 inflammasome in the airway inflammation is observed in COPD. The exposure to cigarette smoke, toxic particles and  gases will activate an inflammatory response in the airways occasioning in the production of a number of potent cytokines and chemokines which play a major role in the stimulation of chronic inflammation and consequent tissue devastation.

  • Track 9-1Genes Responsible
  • Track 9-2Detection of specific genes
  • Track 9-3Biomarkers utilized
  • Track 9-4Population based study

There are many factors can contribute to the occurrence of COPD. Despite the fact cigarette smoking is the number one risk factor in the progression of COPD, recent research has pointed to the concept that genes also play a significant role. A small but vital segment of COPD cases anchorage a major genetic determinant, α1-antitrypsin deficiency (AATD). Intravenous administration with AAT protein is a commonly used treatment for severe AATD in COPD patients.

  • Track 10-1Response to stimuli
  • Track 10-2Genes involved
  • Track 10-3T and B cells involved
  • Track 10-4Population analysis

Paediatric respiratory medicine is a multidisciplinary subspecialty in the specialty of paediatrics, which involves doctors, nurses, respiratory physiologists, physiotherapists, the child. The major reason Paediatric pulmonology arose is relatively late as a specialty of paediatrics is because respiratory problems were so common in the children that all paediatricians were estimated to be specialists in their diagnosis, treatment and management. The majority of paediatric respiratory illnesses are mild and has resolution on their own or respond to treatment given in primary care.


<p justify;\"="">

  • Track 11-1Incidence
  • Track 11-2Rates and mortality
  • Track 11-3Early Diagnosis
  • Track 11-4Treatment

Heart failure is often caused by high blood pressure or coronary artery disease. It’s often directly related to COPD.  The two conditions may influence each other. Low oxygen in the blood from COPD may put extra strain on the heart, which worsens heart failure. The too much fluid in your lungs from heart failure can make breathing even harder if you have COPD.

  • Track 12-1Prevalence
  • Track 12-2Management of risk
  • Track 12-3Incidence
  • Track 12-4Rates and mortality

The first and most important thing to be followed is to quit smoking. Treatment can reduce symptoms, prevent impediments, and generally slow down the disease progression. Medication through the Bronchodilators helps in relaxation of the muscles of the airways Glucocorticosteroids can be added to reduce inflammation in the airways. Although there is medication for COPD but permanent cure is still on research.

  • Track 13-1Usage of Inhalers
  • Track 13-2Usage of Glucocorticosteroids
  • Track 13-3Lung volume reduction surgery
  • Track 13-4Practice of medication

Pulmonary medicine is the branch of medicine that compacts with the causes, diagnosis, prevention and treatment of diseases affecting the lungs. Pulmonary medicine deals with many diseases, such as: ARDS (acute respiratory distress syndrome), asthma, COPD (chronic obstructive pulmonary disease), cystic fibrosis, interstitial lung disease, lung cancer, lung transplants, occupational lung disease, pulmonary hypertension, pulmonary tuberculosis, and SARS (severe acute respiratory syndrome).

  • Track 14-1Treatment by drugs
  • Track 14-2Utilization of antibiotics
  • Track 14-3Therapies
  • Track 14-4Lifestyle preferences

According to the Center for Disease Control and Prevention (CDC) the finest way to prevent getting COPD is to abandon smoking. Mark the environment free from secondhand smoke. The aim of COPD treatment is to dismiss symptoms, slow the deterioration of lung function, decrease exacerbations, and improve quality of life. Pulmonary rehabilitation can progress the well being with special exercises, psychological counselling , COPD education.

  • Track 15-1Treatment
  • Track 15-2Medication
  • Track 15-3Therapies
  • Track 15-4Meditation and exercise

Pulmonary embolism is the formation of  blood clot that occurs in the lungs. It can harm portion of the lung due to restricted blood flow, reduced oxygen levels in the blood, and affect other organs also. Large or multiple blood clots can be lethal. The blockage can be deadly. Pulmonary embolism results in the death of one-third of people who are undiagnosed or untreated. The instant emergency treatment significantly increases your chances of avoiding permanent lung damage.

  • Track 16-1Anatomy of Pulmonary Embolism
  • Track 16-2Etiology
  • Track 16-3Epidemiology
  • Track 16-4Prognosis

Developments in Lung-Volume-Reduction Surgery (LVRS) and lung transplantation offers  the COPD patients improved quality of life to the patients with advanced chronic obstructive pulmonary disease treatment. Currently the number of surgical procedures improved at an almost exponential rate. The operations were done through a median sternotomy and engaged a linear stapling device fitted with the strips of bovine pericardium to minimize the  air leakage through the staple holes.

  • Track 17-1Lung volume reduction surgery
  • Track 17-2Lung transplant
  • Track 17-3Utilization of drugs and therapies
  • Track 17-4Exercise and Medication

Patients untreated for COPD are prone to complications. Common complications include lung infections, Pneumothorax, Heart Problem, Poor Gas Exchange Osteoporosis, Weight Issues, Sleep Problems, Weak Arms and Legs,Diabetes, Depression and Anxiety and many other complications are observed.

  • Track 18-1Lung infections
  • Track 18-2Poor gas exchange
  • Track 18-3Osteoporosis
  • Track 18-4Diabetes